COVID-19 Pandemic - The government presents its daily update
QUÉBEC CITY, June 22, 2021 /CNW Telbec/ - The most recent data on the evolution of COVID-19, in the last 24 hours, in Québec show:
84 new cases, bringing the total number of people infected to 374,095;
361,675 people have recovered;
4 new deaths, for a total of 11,195 deaths:
1 death in the last 24 hours,
2 deaths between June 15 and June 20,
1 death before June 15,
161 hospitalizations, for a decrease of 7;
40 people in intensive care, for an increase of 1;
16,367 samples conducted on June 20.
Vaccination
86,458 doses administered are added, that is 84,121 doses in the last 24 hours and 2,337 doses before June 21, for a total of 7,472,859 doses administered in Québec. Outside Québec, a total of 18,825 doses were administered, for a cumulative total of 7,491,684 doses received by Quebecers.
8,285,035 doses received in total.
Here are the vaccine doses expected this week:
546 990 doses of Pfizer
1 494 920 doses of Moderna
Summary Data Evolution Table1
Date
Confirmed cases
Deaths2
Hospitalizations
Hospitalizations in intensive care
Tests performed
Administered doses of vaccine3
June 15
153
0
192 (-17)
45 (-5)
24,686
86,653
June 16
161
2
178 (-14)
41 (-4)
22,677
97,856
June 17
127
2
175 (-3)
39 (-2)
19,619
101,964
June 18
160
0
178 (+3)
39
17,300
91,281
June 19
103
0
170 (-8)
39
16,307
71,920
June 20
90
2
168 (-2)
39
16,367
57,366
June 21
84
1
161 (-7)
40 (+1)
NA
84,121
1 Note that the majority of data are presented according to the day they were entered. They are extracted at 4 p.m. at the date shown and cover the preceding 24 hours. However, the availability of the data on samples involves an additional delay of 24 hours and these correspond to the number of samples taken on the date shown.
2 It should also be noted that the data prior to those of the last 24 hours presented in the column Deaths have been adjusted according to the actual dates of death. This explains the variation of some data compared to those presented in previous press releases. The daily death toll is influenced by the time required for the physician to report the death, the time required to complete the investigation to confirm that the death was attributable to COVID-19, and the entry into the system.
3 Note that the number of doses administered may be subject to daily readjustment for the previous days, due to catching up due to a delay in data entry.
A reminder concerning public health instructions:
To limit the spread of the coronavirus as much as possible, it is important to follow basic preventive measures such as hand washing, physical distancing, wearing a face covering and following the instructions in effect in your region.
Remember that in the event of symptoms, it is always essential to isolate yourself and consult one of the self-care guides or call 1-877-644-4545 (or the telephone code corresponding to the region concerned) to find out the measures to be taken.
StateHouse Holdings Inc. ("StateHouse" or the "Company") , a California-focused, vertically integrated cannabis company, today announced further to its press release dated April 15, 2024, that the Ontario Securities Commission (the "OSC") has denied...
Grifols, S.A. ("Grifols") (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines, today announces the filing of its Annual Report on Form 20-F for the fiscal year ended December 31,...
Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:
On Thursday, the FDA posted a safety communication to inform the public and healthcare providers that the agency has required and...
Unifor expects to achieve the wage increases and benefit improvements awarded to Ontario OCHU-CUPE and SEIU Healthcare members by Arbitrator William Kaplan in a recent decision....
Acadia Pharmaceuticals Inc. today announced that on April 10, 2024, the Compensation Committee of Acadia's Board of Directors (the "Committee") granted inducement awards consisting of non-qualified stock options to purchase 21,659 shares of common...
Calidi Biotherapeutics, Inc. , a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today announced the closing of its previously announced public offering of 15,197,500 shares of common stock (or pre-funded...